VentriNova
Latest round
- Seed
Last raised
- Sep 2009
Total raised
- $1M
Investors
- 1
About VentriNova
Founded in 2006 and based in New York, US, VentriNova Inc. operates as a biotechnology company that develops regenerative medicines for patients with heart diseases. The firm's products include VN-100, a vector-based gene therapy that causes cardiomyocyte division in adult heart tissue by delivery of the cyclin A2 gene.
Who invested in VentriNova
1 investor across 1 round
See all investors in VentriNova
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Sep 3, 2009
Amount
$1M
Investors
Questions about VentriNova
Who invested in VentriNova?
VentriNova has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has VentriNova raised?
VentriNova has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did VentriNova last raise money?
VentriNova's most recent round on record is a Seed, in Sep 2009.
What does VentriNova do?
Founded in 2006 and based in New York, US, VentriNova Inc.
Where is VentriNova headquartered?
VentriNova is headquartered in New York, US.
Which VCs invest in companies like VentriNova?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at VentriNova's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like VentriNova? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.